₹9.82
▲ +0.19 +1.97%
18 Jul 2026
BSE Listed
GSM 0 · ESM 2Kobo Biotech Limited (531541)
Volume: 5,52,942Avg Vol 1W: 2,98,271Avg Vol 1M: 1,00,48152W Range:₹1.99₹9.82
Key Ratios
Checked just nowMarket Cap₹23 Cr
Current Price₹9.82
Previous Close₹9.63
High / Low (52w)₹9.82 / ₹1.99
Volume5,52,942
Avg Vol (1W)2,98,271
Avg Vol (1M)1,00,481
Stock P/E—
Book Value₹-57.98
Dividend Yield0%
ROE370.84%
ROA-7.06%
Revenue (TTM)—
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding2 Cr
Face Value—
EPS (TTM)₹0
P/B0
Debt / Equity3.38
50 DMA₹5.9
200 DMA₹3.33
Day change+1.97%
SurveillanceGSM 0 · ESM 2 (as of 2026-07-18)
Price Chart
₹9.82▲ 299.19% · 1Y
2025-07-182026-07-17
20-day avg volume: 1.1L shares
Pros
- Healthy return on equity of 370.8%.
- Company is almost debt-free.
Cons
- Revenue fell 74% YoY.
- Company is loss-making at the latest annual result.
- Negative book value per share.
Quarterly Results
| Metric | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EBITDA | ₹-1 Cr | ₹-1 Cr | ₹-2 Cr | ₹-1 Cr | ₹-1 Cr | ₹-1 Cr | ₹-1 Cr | ₹-1 Cr |
| Net Profit | ₹-1 Cr | ₹-1 Cr | ₹-2 Cr | ₹-1 Cr | ₹-1 Cr | ₹-1 Cr | ₹-1 Cr | ₹-1 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 |
|---|---|---|---|---|---|
| Revenue | ₹162 Cr | ₹287 Cr | ₹404 Cr | ₹404 Cr | ₹103 Cr |
| EBITDA | ₹23 Cr | ₹38 Cr | ₹33 Cr | ₹33 Cr | ₹-10 Cr |
| Net Profit | ₹10 Cr | ₹15 Cr | ₹14 Cr | ₹14 Cr | ₹-35 Cr |
| EPS | 4.38 | 6.72 | 6.22 | 6.22 | -15.47 |
Balance Sheet
| Metric | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 |
|---|---|---|---|---|---|
| Total Assets | ₹250 Cr | ₹346 Cr | ₹412 Cr | ₹412 Cr | ₹396 Cr |
| Total Liabilities | ₹189 Cr | ₹270 Cr | ₹324 Cr | ₹324 Cr | ₹343 Cr |
| Equity | ₹61 Cr | ₹76 Cr | ₹88 Cr | ₹88 Cr | ₹53 Cr |
| Total Debt | — | — | — | — | — |
Cash Flow
| Metric | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 |
|---|---|---|---|---|
| Operating | ₹66 Cr | ₹39 Cr | ₹39 Cr | ₹7 Cr |
| Investing | ₹-14 Cr | ₹-7 Cr | ₹-7 Cr | ₹-5 Cr |
| Financing | ₹-27 Cr | ₹-38 Cr | ₹-38 Cr | ₹-13 Cr |
| Free Cash Flow | ₹66 Cr | ₹39 Cr | ₹39 Cr | ₹7 Cr |
Shareholding
Promoter 44.95% Institutions 0% Public 55.05%
Efficiency & Working Capital
ROCE-72.7%
Interest Coverage-0.4
Dividend Payout—
Debtor Days666 d
Inventory Days267 d
Payable Days416 d
Cash Conversion Cycle517 d
Working Capital Days932 d
Shareholding Details
As of 2026-03-31
Promoter44.9%
FII0%
DII0%
Institutions0%
Public55.1%
Promoter Pledge0%
No. of Shareholders7,977
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0.7% | 0.7% | 0.7% | 0.7% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 54.4% | 54.4% | 54.4% | 54.4% | 55.1% | 55.1% | 55.1% | 55.1% | 55.1% | 55.1% | 55.1% | 55.1% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 6,458 | 6,478 | 6,530 | 6,767 | 6,788 | 6,916 | 7,542 | 7,873 | 7,929 | 7,947 | 7,970 | 7,977 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Arch Pharmalabs Ltd | Shareholding of Promoter and Promoter Group | 45% | 1.07 Cr |
| Mehul Pravin Chandra Shah | Public Shareholding | 1.1% | 2,61,696 |
| Sanjay Luthra | Public Shareholding | 1.1% | 2,51,861 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Arch Pharmalabs Ltd | 0 | 0% | 2026-03-31 |
| Mehul Pravin Chandra Shah | 0 | 0% | 2026-03-31 |
| Sanjay Luthra | 0 | 0% | 2026-03-31 |
| Arch Pharmalabs Ltd | 0 | 0% | 2025-12-31 |
| Mehul Pravin Chandra Shah | 0 | 0% | 2025-12-31 |
| Sanjay Luthra | 0 | 0% | 2025-12-31 |
| Arch Pharmalabs Ltd | 0 | 0% | 2025-09-30 |
| Mehul Pravin Chandra Shah | 0 | 0% | 2025-09-30 |
| Sanjay Luthra | 0 | 0% | 2025-09-30 |
| Arch Pharmalabs Ltd | 0 | 0% | 2025-06-30 |
| Mehul Pravin Chandra Shah | 0 | 0% | 2025-06-30 |
| Sanjay Luthra | 0 | 0% | 2025-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Ajit Kamath | Chairman (Non-Executive) | 2022 |
| Rajendra Kaimal | Non-Executive & Non-Independent Director | 2022 |
| Jignesh Patel | Company Sec. & Compli. Officer | 2022 |
| Sunil Pitroda | Non Executive & Independent Director | 2022 |
| Abhishek Buddhadev | Non Executive & Independent Director | 2022 |
| Urja Shah | Non Executive & Independent Director | 2022 |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Domestic | ₹8 Cr | 25.6% |
| Exports | ₹24 Cr | 74.4% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 40 | 24 | 24 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2023 | 0 | 0 | 0 | 0 | 53 | 53 |
| 2023 | 0 | 0 | 0 | 0 | 2 | 2 |
| 2023 | 0 | 0 | 0 | 0 | 51 | 51 |
Company Information
🌐 www.kobobiotech.com ↗
📍 Ground Flr D No 8-2-684/J/8/A, Bhavani Nagar Banjara Hills, Hyderabad, Telangana, 500034
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search